These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1020 related items for PubMed ID: 21087727

  • 41. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
    Yang WF, Tan GZ, Fu Z, Yu JM.
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):925-8. PubMed ID: 20193335
    [Abstract] [Full Text] [Related]

  • 42. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
    [Abstract] [Full Text] [Related]

  • 43. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer.
    Tasci E, Tezel C, Orki A, Akin O, Falay O, Kutlu CA.
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):200-3. PubMed ID: 19933240
    [Abstract] [Full Text] [Related]

  • 44. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
    Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J, Kozuka T, Hosoki T, Hasegawa Y, Takami M, Tomita Y, Kodama K.
    Lung Cancer; 2011 Mar; 71(3):333-7. PubMed ID: 20619479
    [Abstract] [Full Text] [Related]

  • 45. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL, Fischman AJ.
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [Abstract] [Full Text] [Related]

  • 46. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
    Sommer G, Wiese M, Winter L, Lenz C, Klarhöfer M, Forrer F, Lardinois D, Bremerich J.
    Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
    [Abstract] [Full Text] [Related]

  • 47. 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
    Toba H, Sakiyama S, Otsuka H, Kawakami Y, Takizawa H, Kenzaki K, Kondo K, Tangoku A.
    Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):859-64. PubMed ID: 22914804
    [Abstract] [Full Text] [Related]

  • 48. Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer.
    Stokkel MP, Bakker PF, Heine R, Schlösser NJ, Lammers JW, Van Rijk PP.
    Nucl Med Commun; 1999 Nov; 20(11):1001-7. PubMed ID: 10572909
    [Abstract] [Full Text] [Related]

  • 49. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y, Li P, Zhang H, Shi Y, Wu H, Zhang J, Qian Y, Li C, Yang J.
    Int J Cancer; 2013 Jan 15; 132(2):E37-47. PubMed ID: 22890912
    [Abstract] [Full Text] [Related]

  • 50. The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer.
    Maeda R, Isowa N, Onuma H, Miura H, Harada T, Touge H, Tokuyasu H, Kawasaki Y.
    Interact Cardiovasc Thorac Surg; 2009 Jul 15; 9(1):79-82. PubMed ID: 19366724
    [Abstract] [Full Text] [Related]

  • 51. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 15; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 52. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy.
    Eschmann SM, Friedel G, Paulsen F, Budach W, Harer-Mouline C, Dohmen BM, Bares R.
    Eur J Nucl Med Mol Imaging; 2002 Jun 15; 29(6):804-8. PubMed ID: 12029555
    [Abstract] [Full Text] [Related]

  • 53. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
    Yi CA, Lee KS, Lee HY, Kim S, Kwon OJ, Kim H, Choi JY, Kim BT, Hwang HS, Shim YM.
    Cancer; 2013 May 15; 119(10):1784-91. PubMed ID: 23423920
    [Abstract] [Full Text] [Related]

  • 54. Targeted lymph node biopsy in mediastinoscopy using 3D FDG-PET/CT movies: a feasibility study.
    Siepel FJ, de Bruin WI, van Duyn EB, Steenvoorde P, Wagenaar NR, Slump CH, van Dalen JA.
    Nucl Med Commun; 2012 Apr 15; 33(4):439-44. PubMed ID: 22311052
    [Abstract] [Full Text] [Related]

  • 55. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
    Kim BT, Lee KS, Shim SS, Choi JY, Kwon OJ, Kim H, Shim YM, Kim J, Kim S.
    Radiology; 2006 Nov 15; 241(2):501-9. PubMed ID: 16966480
    [Abstract] [Full Text] [Related]

  • 56. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
    Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M, Nishiwaki Y, Suzuki K, Nagai K.
    Lung Cancer; 2005 Feb 15; 47(2):235-42. PubMed ID: 15639722
    [Abstract] [Full Text] [Related]

  • 57. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.
    Acta Radiol; 2009 Jul 15; 50(6):638-44. PubMed ID: 19492198
    [Abstract] [Full Text] [Related]

  • 58. Improvement of non-small-cell lung cancer staging by means of positron emission tomography.
    Albes JM, Lietzenmayer R, Schott U, Schülen E, Wehrmann M, Ziemer G.
    Thorac Cardiovasc Surg; 1999 Feb 15; 47(1):42-7. PubMed ID: 10218620
    [Abstract] [Full Text] [Related]

  • 59. 18F-FDG PET/Contrast-Enhanced CT for Initial Staging and Strategic Treatment of Non-Small Cell Lung Cancer: A Prospective Study.
    Promteangtrong C, Kunawudhi A, Phadungrerk R, Iamsa-art C, Chotipanich C.
    J Med Assoc Thai; 2015 Oct 15; 98(10):1010-8. PubMed ID: 26638593
    [Abstract] [Full Text] [Related]

  • 60. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.
    Abramyuk A, Appold S, Zöphel K, Hietschold V, Baumann M, Abolmaali N.
    Lung Cancer; 2012 Nov 15; 78(2):148-52. PubMed ID: 22922126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.